Palczewski Krzysztof
Department of Pharmacology, Cleveland Center for Membrane and Structural Biology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, United States.
Invest Ophthalmol Vis Sci. 2014 Oct 22;55(10):6651-72. doi: 10.1167/iovs.14-15502.
Visual transduction is the process in the eye whereby absorption of light in the retina is translated into electrical signals that ultimately reach the brain. The first challenge presented by visual transduction is to understand its molecular basis. We know that maintenance of vision is a continuous process requiring the activation and subsequent restoration of a vitamin A-derived chromophore through a series of chemical reactions catalyzed by enzymes in the retina and retinal pigment epithelium (RPE). Diverse biochemical approaches that identified key proteins and reactions were essential to achieve a mechanistic understanding of these visual processes. The three-dimensional arrangements of these enzymes' polypeptide chains provide invaluable insights into their mechanisms of action. A wealth of information has already been obtained by solving high-resolution crystal structures of both rhodopsin and the retinoid isomerase from pigment RPE (RPE65). Rhodopsin, which is activated by photoisomerization of its 11-cis-retinylidene chromophore, is a prototypical member of a large family of membrane-bound proteins called G protein-coupled receptors (GPCRs). RPE65 is a retinoid isomerase critical for regeneration of the chromophore. Electron microscopy (EM) and atomic force microscopy have provided insights into how certain proteins are assembled to form much larger structures such as rod photoreceptor cell outer segment membranes. A second challenge of visual transduction is to use this knowledge to devise therapeutic approaches that can prevent or reverse conditions leading to blindness. Imaging modalities like optical coherence tomography (OCT) and scanning laser ophthalmoscopy (SLO) applied to appropriate animal models as well as human retinal imaging have been employed to characterize blinding diseases, monitor their progression, and evaluate the success of therapeutic agents. Lately two-photon (2-PO) imaging, together with biochemical assays, are revealing functional aspects of vision at a new molecular level. These multidisciplinary approaches combined with suitable animal models and inbred mutant species can be especially helpful in translating provocative cell and tissue culture findings into therapeutic options for further development in animals and eventually in humans. A host of different approaches and techniques is required for substantial progress in understanding fundamental properties of the visual system.
视觉转导是眼睛中的一个过程,即视网膜中光的吸收被转化为最终到达大脑的电信号。视觉转导面临的首要挑战是了解其分子基础。我们知道,视觉的维持是一个持续的过程,需要通过视网膜和视网膜色素上皮(RPE)中酶催化的一系列化学反应来激活并随后恢复维生素A衍生的发色团。确定关键蛋白质和反应的各种生化方法对于从机制上理解这些视觉过程至关重要。这些酶的多肽链的三维排列为其作用机制提供了宝贵的见解。通过解析视紫红质和色素RPE中的类视黄醇异构酶(RPE65)的高分辨率晶体结构,已经获得了大量信息。视紫红质通过其11-顺式视黄叉发色团的光异构化而被激活,是一大类称为G蛋白偶联受体(GPCR)的膜结合蛋白的典型成员。RPE65是一种对发色团再生至关重要的类视黄醇异构酶。电子显微镜(EM)和原子力显微镜已经揭示了某些蛋白质如何组装形成更大的结构,如视杆光感受器细胞外段膜。视觉转导的第二个挑战是利用这些知识设计出能够预防或逆转导致失明的病症的治疗方法。应用于适当动物模型以及人类视网膜成像的光学相干断层扫描(OCT)和扫描激光检眼镜(SLO)等成像方式已被用于表征致盲疾病、监测其进展以及评估治疗药物的效果。最近,双光子(2-PO)成像与生化分析一起,正在新的分子水平上揭示视觉的功能方面。这些多学科方法与合适的动物模型和近交突变物种相结合,对于将引人注目的细胞和组织培养研究结果转化为可在动物中进一步开发并最终应用于人类的治疗选择可能特别有帮助。要在理解视觉系统的基本特性方面取得实质性进展,需要许多不同的方法和技术。